Finland
· Delayed Price · Currency is EUR Optomed Oyj Statistics
Total Valuation
Optomed Oyj has a market cap or net worth of EUR 76.91 million. The enterprise value is 69.68 million.
| Market Cap | 76.91M |
| Enterprise Value | 69.68M |
Important Dates
The last earnings date was Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Optomed Oyj has 19.60 million shares outstanding. The number of shares has increased by 13.57% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.60M |
| Shares Change (YoY) | +13.57% |
| Shares Change (QoQ) | +3.97% |
| Owned by Insiders (%) | 0.50% |
| Owned by Institutions (%) | 53.48% |
| Float | 14.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.27 |
| PB Ratio | 3.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.63 |
| EV / Sales | 5.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -25.92 |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.29 |
| Quick Ratio | 2.76 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.39 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.83% and return on invested capital (ROIC) is -12.88%.
| Return on Equity (ROE) | -25.83% |
| Return on Assets (ROA) | -11.29% |
| Return on Capital (ROIC) | -12.88% |
| Revenue Per Employee | 120,363 |
| Profits Per Employee | -53,009 |
| Employee Count | 114 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +25.00% |
| 50-Day Moving Average | 4.37 |
| 200-Day Moving Average | 4.92 |
| Relative Strength Index (RSI) | 45.31 |
| Average Volume (20 Days) | 80,273 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Optomed Oyj had revenue of EUR 13.60 million and -5.99 million in losses. Loss per share was -0.33.
| Revenue | 13.60M |
| Gross Profit | 8.81M |
| Operating Income | -5.76M |
| Pretax Income | -6.06M |
| Net Income | -5.99M |
| EBITDA | -4.83M |
| EBIT | -5.76M |
| Loss Per Share | -0.33 |
Balance Sheet
The company has 10.96 million in cash and 3.73 million in debt, giving a net cash position of 7.23 million or 0.37 per share.
| Cash & Cash Equivalents | 10.96M |
| Total Debt | 3.73M |
| Net Cash | 7.23M |
| Net Cash Per Share | 0.37 |
| Equity (Book Value) | 24.70M |
| Book Value Per Share | 1.26 |
| Working Capital | 11.58M |
Cash Flow
In the last 12 months, operating cash flow was -2.50 million and capital expenditures -187,000, giving a free cash flow of -2.69 million.
| Operating Cash Flow | -2.50M |
| Capital Expenditures | -187,000 |
| Free Cash Flow | -2.69M |
| FCF Per Share | -0.14 |
Margins
Gross margin is 64.80%, with operating and profit margins of -42.33% and -44.04%.
| Gross Margin | 64.80% |
| Operating Margin | -42.33% |
| Pretax Margin | -44.57% |
| Profit Margin | -44.04% |
| EBITDA Margin | -35.52% |
| EBIT Margin | -42.33% |
| FCF Margin | -19.76% |
Dividends & Yields
Optomed Oyj does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.57% |
| Shareholder Yield | -13.57% |
| Earnings Yield | -8.35% |
| FCF Yield | -3.49% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Optomed Oyj has an Altman Z-Score of 5.13.
| Altman Z-Score | 5.13 |
| Piotroski F-Score | n/a |